Clinical Trial Update: Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reporting a Phase 1/Phase 2 efficacy study of Andrographis Paniculata Purified Standardized Extract (ApE) in relapsing-remitting multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Andrographis Paniculata Purified Standardized Extract (ApE) (Andrographis paniculata purified standardized extract)

Snippet

Sponsor: Universidad Austral de Chile | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 1, Phase 2 | Status: COMPLETED